Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tacrolimus versus hydrocortisone in management of atopic dermatitis in children, a randomized controlled double-blind study: New insights on TARC, CTACK, TSLP, and E-selectin.
Binsaleh AY, Kotkata FA, Bahaa MM, Hamouda AO, El-Gammal MA, Elberri AI, Selim HM, El-Samongy MA, Hamouda MA, Mokhtar FA, Fahmy SA, Elmasri TA, Elberri EI. Binsaleh AY, et al. Among authors: elberri ei. Immun Inflamm Dis. 2024 Nov;12(11):e70028. doi: 10.1002/iid3.70028. Immun Inflamm Dis. 2024. PMID: 39588929 Free PMC article. Clinical Trial.
Fenofibrate as an Adjunct Therapy for Ulcerative Colitis: Targeting Inflammation via SIRT1, NLRP3, and AMPK Pathways: A Randomized Controlled Pilot Study.
Alarfaj SJ, Bahaa MM, Elmasry TA, Elberri EI, El-Khateeb E, Hamouda AO, Salahuddin MM, Kamal M, Gadallah AA, Eltantawy N, Yasser M, Negm WA, Hamouda MA, Alsegiani AS, Alrubia S, Eldesoqui M, Abdallah MS. Alarfaj SJ, et al. Among authors: elberri ei. Drug Des Devel Ther. 2024 Nov 16;18:5239-5253. doi: 10.2147/DDDT.S490772. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39575188 Free PMC article. Clinical Trial.
Corrigendum: Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study.
Aldossary KM, Saad Ali L, Abdallah MS, Bahaa MM, Elmasry TA, Elberri EI, Kotkata FA, El Sabaa RM, Elmorsi YM, Kamel MM, Negm WA, Elberri AI, Hamouda AO, AlRasheed HA, Salahuddin MM, Yasser M, Hamouda MA. Aldossary KM, et al. Among authors: elberri ei. Front Pharmacol. 2024 Aug 29;15:1464358. doi: 10.3389/fphar.2024.1464358. eCollection 2024. Front Pharmacol. 2024. PMID: 39268472 Free PMC article.
A randomized controlled trial comparing tacrolimus versus hydrocortisone for the treatment of atopic dermatitis in children: new perspectives on interferon gamma-induced protein and growth-related oncogene-α.
Binsaleh AY, Bahaa MM, Elmasry TA, Elberri EI, Kotkata FA, El-Khateeb E, Kamal M, El-Samongy MA, Hamouda AO, Alghamdi AM, Alrubia S, Salahuddin MM, Eltantawy N. Binsaleh AY, et al. Among authors: elberri ei. Front Med (Lausanne). 2024 Jul 24;11:1399305. doi: 10.3389/fmed.2024.1399305. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39114823 Free PMC article.
Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study.
Aldossary KM, Ali LS, Abdallah MS, Bahaa MM, Elmasry TA, Elberri EI, Kotkata FA, El Sabaa RM, Elmorsi YM, Kamel MM, Negm WA, Elberri AI, Hamouda AO, AlRasheed HA, Salahuddin MM, Yasser M, Hamouda MA. Aldossary KM, et al. Among authors: elberri ei. Front Pharmacol. 2024 May 24;15:1381523. doi: 10.3389/fphar.2024.1381523. eCollection 2024. Front Pharmacol. 2024. PMID: 38855751 Free PMC article.
A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new insights on serum STAT-3 and hepassocin.
Alarfaj SJ, Bahaa MM, Yassin HA, El-Khateeb E, Kotkata FA, El-Gammal MA, Elberri AI, Habba E, Zien El-Deen EE, Khrieba MO, El-Masry TA, Negm WA, Elberri EI. Alarfaj SJ, et al. Among authors: elberri ei. Eur Rev Med Pharmacol Sci. 2023 Aug;27(16):7607-7619. doi: 10.26355/eurrev_202308_33413. Eur Rev Med Pharmacol Sci. 2023. PMID: 37667938 Free article. Clinical Trial.
Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial.
El-Khateeb E, El-Berri EI, Mosalam EM, Nooh MZ, Abdelsattar S, Alghamdi AM, Alrubia S, Abdallah MS. El-Khateeb E, et al. Front Pharmacol. 2023 Apr 11;14:1153653. doi: 10.3389/fphar.2023.1153653. eCollection 2023. Front Pharmacol. 2023. PMID: 37113754 Free PMC article.
Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial.
Abdallah MS, Mosalam EM, Hassan A, Ramadan AN, Omara-Reda H, Zidan AA, Samman WA, El-Berri EI. Abdallah MS, et al. CNS Neurosci Ther. 2023 Jan;29(1):354-364. doi: 10.1111/cns.14010. Epub 2022 Nov 7. CNS Neurosci Ther. 2023. Retraction in: CNS Neurosci Ther. 2024 Mar;30(3):e14668. doi: 10.1111/cns.14668 PMID: 36341700 Free PMC article. Retracted. Clinical Trial.